The United States should avoid imposing tariffs on pharmaceutical imports, as such measures would disrupt global medical supply chains, drive up healthcare costs for American consumers, and undermine ...

Roche has pledged to build a giant weight-loss drug factory in the US. The plans form part of a $50bn (£37bn) pledge aimed at ...

The Global Active Pharmaceutical Ingredients Market achieved a valuation of $209.80 Billion in 2024 and is anticipated to exceed $445.7 Billion by 2035, reflecting a compounded annual growth rate ...

In the meantime, have a read of Emma Hanrahan’s piece on the Kingspan chief receiving backing from investor advisory firm ...

Molex, a global leader in electronics and interconnectivity solutions, is a shining example of how to leverage advanced ...

For supply chain executives, the Earth Day message is clear: the path to a more sustainable planet runs directly through your ...

Our analysis revealed that supply chain co-location can drive significant improvements for companies. The best-case scenario, ...

AVI-SPL Global Supply Chain team is fast-growing and offers the integrator a strong point of positive differentiation.

Inside the transformation of our global food systems – download this report to discover insights from the experts shaping the ...

Swedish medical equipment maker Getinge said U.S. tariffs would not undo decades of global supply chains, after it reported quarterly core earnings just below market expectations on Tuesday.

In most health systems, quality and clinical transformation are viewed as open-ended commitments. Important, yes, but often treated like blank checks with unclear ROI. Supply chain, in contrast, is ...